NCT02605083 2020-11-02A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid TumorsEffector TherapeuticsPhase 1/2 Terminated66 enrolled
NCT03176485 2019-01-04Evaluation of Pathway Modulation by Raf, MEK, & Kinase InhibitorsUniversity of ArizonaPhase NA Completed45 enrolled